<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Daily Stocks News &#187; BIIB</title>
	<atom:link href="http://news.dailystocks.com/tag/biib/feed/" rel="self" type="application/rss+xml" />
	<link>http://news.dailystocks.com</link>
	<description>Stocks with Insider Buying, Stock Search Engine, Glossary, Education, Reviews</description>
	<lastBuildDate>Mon, 21 Jan 2019 17:42:26 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>Major Movers on April 22; NFLX, BIIB, SIX, NVR, HAL</title>
		<link>http://news.dailystocks.com/2833/major-movers-on-april-22-nflx-biib-six-nvr-hal/</link>
		<comments>http://news.dailystocks.com/2833/major-movers-on-april-22-nflx-biib-six-nvr-hal/#comments</comments>
		<pubDate>Mon, 22 Apr 2013 18:12:51 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[BIIB]]></category>
		<category><![CDATA[HAL]]></category>
		<category><![CDATA[NFLX]]></category>
		<category><![CDATA[NVR]]></category>
		<category><![CDATA[SIX]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=2833</guid>
		<description><![CDATA[<p>Shares movie streaming and DVD rental Company Netflix Inc. (NASDAQ: NFLX) climbed about 5.60% by afternoon trade after analysts at at B. Riley &#38; Co upgraded the stock from “sell” to “buy” rating, and boosted the price target on the stock to $165 from $90. Earlier on April 15, another equity research firm BS AG [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/2833/major-movers-on-april-22-nflx-biib-six-nvr-hal/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Major Movers on March 28; FIVE, PVH, BBRY, BIIB</title>
		<link>http://news.dailystocks.com/2677/major-movers-on-march-28-five-pvh-bbry-biib/</link>
		<comments>http://news.dailystocks.com/2677/major-movers-on-march-28-five-pvh-bbry-biib/#comments</comments>
		<pubDate>Thu, 28 Mar 2013 16:28:15 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[BBRY]]></category>
		<category><![CDATA[BIIB]]></category>
		<category><![CDATA[FIVE]]></category>
		<category><![CDATA[PVH]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=2677</guid>
		<description><![CDATA[<p>Shares of Five Below Inc. (NASDAQ: FIVE) slumped in early trade after the discount retailer, which focuses on teenagers and preteen consumers, late last evening, provided downbeat guidance on the current fiscal year. However, fiscal fourth quarter results edged past analysts’ estimations.</p> <p></p> <p>For the quarter which concluded on Feb 2, the Philadelphia PA based [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/2677/major-movers-on-march-28-five-pvh-bbry-biib/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Approves Biogen Idec’s Potential Blockbuster Treatment for MS (BIIB)</title>
		<link>http://news.dailystocks.com/2669/fda-approves-biogen-idecs-potential-blockbuster-treatment-for-ms-biib/</link>
		<comments>http://news.dailystocks.com/2669/fda-approves-biogen-idecs-potential-blockbuster-treatment-for-ms-biib/#comments</comments>
		<pubDate>Thu, 28 Mar 2013 11:15:44 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[BIIB]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=2669</guid>
		<description><![CDATA[<p>Shares of Biogen Idec Inc. (NASDAQ: BIIB) gained in premarket hours on Thursday after the FDA said late on Wednesday that it has approved the biotechnology Company’s new multiple sclerosis drug, Tecfidera.</p> <p></p> <p>The FDA’s approval will help the Weston, Massachusetts-based Company to cement its control in the market of MS treatments since it’s a [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/2669/fda-approves-biogen-idecs-potential-blockbuster-treatment-for-ms-biib/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biogen Idec Shares Rise Sharply on Q4 Results (BIIB)</title>
		<link>http://news.dailystocks.com/2277/biogen-idec-shares-rise-sharply-on-q4-results-biib/</link>
		<comments>http://news.dailystocks.com/2277/biogen-idec-shares-rise-sharply-on-q4-results-biib/#comments</comments>
		<pubDate>Mon, 28 Jan 2013 15:34:38 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[BIIB]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=2277</guid>
		<description><![CDATA[<p>Shares of Biogen Idec Inc. (NASDAQ: BIIB), a global biotechnology company, have risen sharply in early trading today after the Weston, Massachusetts-based company reported its fourth-quarter and full-year 2012 financial results.</p> <p></p> <p>For the fourth quarter of 2012, BIIB reported revenue of $1.4 billion, representing an increase of 7% over the same period in the [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/2277/biogen-idec-shares-rise-sharply-on-q4-results-biib/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
